Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Monia Sisi
Observed names:
M. Sisi,
Sisi, Monia
Institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
University of Bologna
Observed institutions:
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola,
Institute of Neurological Sciences,
University of Bologna
ORCID:
0000-0002-0395-6038
Observed ORCID:
0000-0002-0395-6038
OpenAlex ID:
A5031928109
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma
2020
·
Giuseppe Lamberti
, Elisa Andrini
, et al.
·
Critical Reviews in Oncology/Hematology
·
152
The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?
2020
·
Giuseppe Lamberti
, Monia Sisi
, et al.
·
Cancers
·
69
PDF
Targeting DNA Damage Response and Repair Genes to Enhance Anticancer Immunotherapy: Rationale and Clinical Implication
2020
·
Giuseppe Lamberti
, Elisa Andrini
, et al.
·
Future Oncology
·
36
Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System
2022
·
Monia Sisi
, Michele Fusaroli
, et al.
·
Targeted Oncology
·
28
PDF
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors
2023
·
Monia Sisi
, Giovanni Vitale
, et al.
·
JTO Clinical and Research Reports
·
16
PDF
PD-L1 ≥ 50% Lung Cancer Refractory to PD-1 Inhibition: The Role of Salvage Chemo-Immunotherapy Combination
2021
·
Francesco Gelsomino
, Francesco Facchinetti
, et al.
·
Immunotherapy
·
9
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?
2020
·
Alessandro Di Federico
, Giacomo Nuvola
, et al.
·
Anti-Cancer Drugs
·
9
Immune Checkpoint Inhibitors in Lung Tumors with Rare Histologies and Other Thoracic Malignancies
2022
·
Elisa Andrini
, Alessandro Di Federico
, et al.
·
Immunotherapy
·
1
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: a case report within the experience of a single institution
2021
·
Alessandro Di Federico
, Elisa Andrini
, et al.
·
Anti-Cancer Drugs
PDF
378P MGMT status influences prognosis of patients with IDH wild type grade III gliomas
2020
·
E. Franceschi
, V. Di Nunno
, et al.
·
Annals of Oncology
PDF
367MO Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective, observational study
2020
·
L. Gatto
, A. Tosoni
, et al.
·
Annals of Oncology
PDF
Show more works
View as search
Works count:
12
Citation count:
320
H-index:
7
I10-index:
5
Year
Topic
Type